236 related articles for article (PubMed ID: 27978517)
1. Management of Fetal and Neonatal Graves' Disease.
Léger J
Horm Res Paediatr; 2017; 87(1):1-6. PubMed ID: 27978517
[TBL] [Abstract][Full Text] [Related]
2. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
[TBL] [Abstract][Full Text] [Related]
3. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
Momotani N
Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring.
Gietka-Czernel M; Dębska M; Kretowicz P; Zgliczyński W; Ołtarzewski M
Endokrynol Pol; 2014; 65(4):259-68. PubMed ID: 25185847
[TBL] [Abstract][Full Text] [Related]
6. [Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Rink T; Wieg C; Schroth HJ; Helisch A; Bertram U
Nuklearmedizin; 1999; 38(5):156-9. PubMed ID: 10488483
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
8. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
10. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
11. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
[No Abstract] [Full Text] [Related]
12. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
13. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
14. Fetal and neonatal thyroid function in relation to maternal Graves' disease.
Polak M; Le Gac I; Vuillard E; Guibourdenche J; Leger J; Toubert ME; Madec AM; Oury JF; Czernichow P; Luton D
Best Pract Res Clin Endocrinol Metab; 2004 Jun; 18(2):289-302. PubMed ID: 15157841
[TBL] [Abstract][Full Text] [Related]
15. Management of thyrotoxicosis during pregnancy.
Andersen SL; Knøsgaard L
Best Pract Res Clin Endocrinol Metab; 2020 Jul; 34(4):101414. PubMed ID: 32199749
[TBL] [Abstract][Full Text] [Related]
16. Severe fetal and neonatal hyperthyroidism years after surgical treatment of maternal Graves' disease.
Dierickx I; Decallonne B; Billen J; Vanhole C; Lewi L; De Catte L; Verhaeghe J
J Obstet Gynaecol; 2014 Feb; 34(2):117-22. PubMed ID: 24456429
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine.
Bliddal S; Rasmussen ÅK; Sundberg K; Brocks V; Skovbo P; Feldt-Rasmussen U
Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688
[TBL] [Abstract][Full Text] [Related]
18. Fetal and Neonatal Thyroid Dysfunction.
Léger J; Delcour C; Carel JC
J Clin Endocrinol Metab; 2022 Feb; 107(3):836-846. PubMed ID: 34636892
[TBL] [Abstract][Full Text] [Related]
19. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
20. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
van Dijk MM; Smits IH; Fliers E; Bisschop PH
Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
